{'fraction_non_alphanumeric': 0.0310192023633678, 'fraction_numerical': 0.0, 'mean_word_length': 6.450549450549451, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cardiac and proinflammatory markers predict prognosis in cirrhosis

Inflammation and cardiac dysfunction plays an important role in the development of complications leading to increased mortality in patients with cirrhosis. Novel cardiac markers such as prohormone of ANP (proANP), copeptin and high‐sensitivity troponin T (hs‐TnT) and proinflammatory markers including soluble urokinase‐type plasminogen activator receptor (suPAR) and high‐sensitive C‐reactive protein (hs‐CRP) are related to these complications. We aimed to investigate if cardiac and proinflammatory markers are related to severity of liver disease, cardiac and haemodynamic changes, and long‐term survival.